Hotel Riu Plaza Berlin
Martin-Luther-Straße 1, 10777
This 3rd Annual Summit brings together industry experts to explore strategies and gain insight into designing new biosimilar development programmes and analysis methods, clinical advancement, and new solutions for successful implementation in the market.
It is a great environment for interactive networking, learning best practice, maintaining business relationships, and meeting new clients.
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
From Industries Including:
Caroline Bouilliat Commercial Lead (Biosimilars) Amgen, Switzerland
Bernd Liedert Senior Director, Clinical Development Biosimilars Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Dr. Steinar Madsen Medical Director Norwegian Medicines Agency
Dr. Uwe Gudat Head of Safety Biosimilars Merck, Switzerland
Matthew Turner Global Medical Director Biosimilars Merck, Switzerland
Scott Davis Senior Director Therapeutic Science & Strategy QuintilesIMS, UK
To register for the Summit, please provide the details below. We will send you a registration form in return. Please fill out, print, sign, and send back the registration form to [firstname.lastname@example.org], to successfully register. Upon receiving the registration form, we will send you an invoice for payment.
To request an agenda for this Summit, please complete the details below. We will send an agenda to you via email.
To buy a documentation package for this Summit, please complete the details below. Upon receiving this form we will send an invoice for the documentation package. The cost for the documentation package is €500. Upon successfully receiving payment, we will send you the documentation package.